Jasper Therapeutics, Inc. (JSPR) vs MetaVia Inc. (MTVA)
A side-by-side comparison of Jasper Therapeutics, Inc. and MetaVia Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
JSPR
Jasper Therapeutics, Inc.
$0.57HealthcareDelayed quote: Oct 6, 2026, 10:50 AM EDT
MTVA
MetaVia Inc.
$1.53HealthcareDelayed quote: Oct 6, 2026, 10:46 AM EDT
Total return — JSPR vs MTVA
growth of $100 · dividends reinvested · last 2yJSPR -97.3% (-83.6%/yr)MTVA -94.5% (-76.5%/yr)MTVA compounded faster over this window
JSPR MTVA
JSPR vs MTVA: by the numbers
- •MTVA is the larger company ($10M vs $9M market cap).
Metrics side by side
Valuation
| Metric | JSPR | MTVA |
|---|---|---|
| P/B ratio | 6.54 | 1.48 |
Profitability
| Metric | JSPR | MTVA |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -2248.48% | -211.76% |
| ROIC | -1394.09% | -215.61% |
Growth (annualized)
| Metric | JSPR | MTVA |
|---|---|---|
| Total return CAGR (5Y) | -62.51% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.